Delivery Order SPE2DB22D1202-SPE2DB24FVMY8
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Vyvanse 30 mg capsules in 100-count packages to the Defense Logistics Agency (DLA). The $9,748.40 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
The federal contract award is for the delivery of Vyvanse capsules, 30mg, to the Defense Logistics Agency (DLA). The $16,721.57 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a major defense agency of the U.S. government. The $3,488.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor. This contract is a child of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the delivery of Vyvanse capsules (40mg) to the Defense Logistics Agency (DLA), a defense agency. The $34,466.34 firm-fixed-price delivery order contract has a period of performance through May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This federal contract award is for the delivery of Vyvanse 50mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The $4,992.76 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 19, 2024. The contract has an ultimate completion date of November 20, 2024 and was not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2025 for a ceiling value of $4,906.88. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of 4,566,708,453 units of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,626.84 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024 with a completion date of December 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the supply of Vyvanse 50 mg capsules (100s) to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $5,343.24 and has an ultimate completion date of August 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 50 mg capsules in 100-count packages to the U.S. Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024, with a completion date of August 26, 2024. The contract has a firm fixed price of $1,706.30 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued...
This federal contract award is for the delivery of Vyvanse 30mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,012.21 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...